{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:05:36Z","timestamp":1780077936280,"version":"3.54.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Therapeutic efficacy studies (TESs) are the standard to evaluate antimalarial drug efficacy and guide malaria treatment policy. TESs are particularly relevant now, with resistance to first-line regimens emerging in sub-Saharan Africa. For TESs, a range of parasite genotyping and data analyses are available for genotype correction, a process to distinguish whether recurrent parasitemia after therapy is due to recrudescence of initially infecting parasites (treatment failure) or a new infection. The choice of methods for laboratory genotyping and data analyses can have a large effect on how outcomes are classified, and thereby on trial results. The currently recommended and most widely used laboratory and analytical methods for TES genotyping do not incorporate recent methodological advances and can produce biased results. As such current TES results can be difficult to interpret, especially in areas with high malaria transmission, such as much of sub-Saharan Africa. Thus, improving the accuracy and reliability of TES genotyping and data analysis are a major priority. To that end, we present target product profiles that outline key specifications for genetic data generation, processing, and data analysis, with the goal of creating rigorous and consistent community standards. Primary recommended specifications for laboratory methods include high sensitivity, specificity, and reproducibility, and guidance on the number and genetic diversity of targets; criteria which are best and likely only met by amplicon sequencing. Primary recommendations for data analysis methods include high classification accuracy, accounting for errors in genotyping, and accounting for alleles matching by chance. All laboratory and data analysis methods used should be systematically validated and publicly documented so that TES results, which have major policy implications, can be relied upon for sound programmatic decision making.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006500","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:26:01Z","timestamp":1780075561000},"page":"e0006500","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy"],"prefix":"10.1371","volume":"6","author":[{"given":"Mateusz M.","family":"Plucinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-3575","authenticated-orcid":true,"given":"Amy","family":"Wesolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Gerlovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Aranda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8459-9983","authenticated-orcid":true,"given":"Monica","family":"Golumbeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-5153","authenticated-orcid":true,"given":"Marko","family":"Bajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L. N.","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Buckee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awa B.","family":"Deme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-2606","authenticated-orcid":true,"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ghansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-742X","authenticated-orcid":true,"given":"Ian","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-5136","authenticated-orcid":true,"given":"Johanna Helena","family":"Kattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-4495","authenticated-orcid":true,"given":"Didier","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-1119","authenticated-orcid":true,"given":"Leah F.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1665-9323","authenticated-orcid":true,"given":"Daniel","family":"Neafsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Okell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Oyier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishree","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-5203","authenticated-orcid":true,"given":"Anna","family":"Rosanas-Urgell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Verity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Volkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nsanzabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-9111","authenticated-orcid":true,"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"7572","key":"pgph.0006500.ref001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"S Bhatt","year":"2015","journal-title":"Nature"},{"issue":"9","key":"pgph.0006500.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"PJ Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"pgph.0006500.ref003","unstructured":"World Health Organization. Methods for surveillance of antimalarial drug efficacy [Internet]. [cited 2024 May 6]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241597531"},{"issue":"11","key":"pgph.0006500.ref004","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0169-4758(98)01340-4","article-title":"The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment","volume":"14","author":"G Snounou","year":"1998","journal-title":"Parasitol Today"},{"issue":"5","key":"pgph.0006500.ref005","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4269\/ajtmh.20-1481","article-title":"Variation in calculating and reporting antimalarial efficacy against Plasmodium falciparum in sub-Saharan Africa: a systematic review of published reports","volume":"104","author":"MM Plucinski","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"pgph.0006500.ref006","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/AAC.00159-07","article-title":"Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials","volume":"51","author":"B Greenhouse","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pgph.0006500.ref007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01517-19","article-title":"A computer modelling approach to evaluate the accuracy of microsatellite markers for classification of recurrent infections during routine monitoring of antimalarial drug efficacy","volume":"64","author":"S Jones","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"pgph.0006500.ref008","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.pt.2022.08.005","article-title":"WHO antimalarial trial guidelines: good science, bad news?","volume":"38","author":"IM Hastings","year":"2022","journal-title":"Trends Parasitol"},{"issue":"5","key":"pgph.0006500.ref009","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4269\/ajtmh.2006.75.836","article-title":"Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections","volume":"75","author":"B Greenhouse","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"pgph.0006500.ref010","doi-asserted-by":"crossref","first-page":"100914","DOI":"10.1016\/S2666-5247(24)00153-8","article-title":"Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study","volume":"5","author":"A Schnoz","year":"2024","journal-title":"Lancet Microbe"},{"key":"pgph.0006500.ref011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1475-2875-5-122","article-title":"The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005","volume":"5","author":"WJ Collins","year":"2006","journal-title":"Malar J"},{"key":"pgph.0006500.ref012","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","author":"Medicines for Malaria Venture, World Health Organization","year":"2008"},{"key":"pgph.0006500.ref013","unstructured":"World Health Organization. Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas [Internet]. [cited 2023 Mar 9]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240038363"},{"issue":"10","key":"pgph.0006500.ref014","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1128\/AAC.00072-15","article-title":"Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping","volume":"59","author":"MM Plucinski","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pgph.0006500.ref015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4269\/ajtmh.21-0117","article-title":"Nonparametric binary classification to distinguish closely related versus unrelated Plasmodium falciparum parasites","volume":"104","author":"MM Plucinski","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pgph.0006500.ref016","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01500-16","article-title":"Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers","volume":"61","author":"C Messerli","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pgph.0006500.ref017","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30426-8","article-title":"PCR correction strategies for malaria drug trials: updates and clarifications","volume":"20","author":"I Felger","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pgph.0006500.ref018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pt.2009.12.007","article-title":"The perils of PCR: can we accurately \u201ccorrect\u201d antimalarial trials?","volume":"26","author":"JJ Juliano","year":"2010","journal-title":"Trends Parasitol"},{"issue":"10","key":"pgph.0006500.ref019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00437-21","article-title":"Should deep-sequenced amplicons become the new gold standard for analyzing malaria drug clinical trials?","volume":"65","author":"S Jones","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"pgph.0006500.ref020","article-title":"Classification of outcomes in antimalarial therapeutic efficacy studies with Aster","author":"I Gerlovina","year":"2026","journal-title":"Antimicrob Agents Chemother"},{"key":"pgph.0006500.ref021","article-title":"Probabilistic classification of late treatment failure in uncomplicated malaria [Internet]","author":"S Mehra","year":"2025","journal-title":"medRxiv"},{"issue":"1","key":"pgph.0006500.ref022","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41597-022-01710-x","article-title":"Introducing the FAIR Principles for research software","volume":"9","author":"M Barker","year":"2022","journal-title":"Sci Data"},{"issue":"12","key":"pgph.0006500.ref023","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/s41591-023-02641-9","article-title":"Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa","volume":"29","author":"T Emiru","year":"2023","journal-title":"Nat Med"},{"issue":"8","key":"pgph.0006500.ref024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of partial resistance to artemisinins in malaria parasites in Uganda","volume":"389","author":"MD Conrad","year":"2023","journal-title":"N Engl J Med"},{"issue":"10472","key":"pgph.0006500.ref025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(24)02706-5","article-title":"Regional action needed to halt antimalarial drug resistance in Africa","volume":"405","author":"R Martinez-Vega","year":"2025","journal-title":"Lancet"},{"key":"pgph.0006500.ref026","article-title":"Towards an open analysis ecosystem for Plasmodium genomic epidemiology [Internet]","author":"S Ruybal-Pes\u00e1ntez","year":"2025","journal-title":"medRxiv"},{"issue":"19","key":"pgph.0006500.ref027","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1016\/j.cell.2024.08.032","article-title":"Africa in the era of pathogen genomics: unlocking data barriers","volume":"187","author":"G Mboowa","year":"2024","journal-title":"Cell"},{"key":"pgph.0006500.ref028","article-title":"Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial","author":"MR Kamya","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pgph.0006500.ref029","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01525-23","article-title":"Therapeutic response to four artemisinin-based combination therapies in Angola, 2021","volume":"68","author":"PR Dimbu","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pgph.0006500.ref030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12936-021-04021-5","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda","volume":"20","author":"C Ebong","year":"2021","journal-title":"Malar J"},{"issue":"4","key":"pgph.0006500.ref031","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"LF Moriarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pgph.0006500.ref032","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018","volume":"20","author":"A Gansan\u00e9","year":"2021","journal-title":"Malar J"},{"issue":"9","key":"pgph.0006500.ref033","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00207-22","article-title":"Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria among children in Western Kenya, 2016 to 2017","volume":"66","author":"N Westercamp","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pgph.0006500.ref034","doi-asserted-by":"crossref","first-page":"17790","DOI":"10.1038\/s41598-019-54203-0","article-title":"Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs","volume":"9","author":"M Gruenberg","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"pgph.0006500.ref035","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/s00436-023-07991-4","article-title":"Simultaneous targeted amplicon deep sequencing and library preparation for a time and cost-effective universal parasite diagnostic sequencing approach","volume":"122","author":"M Gondard","year":"2023","journal-title":"Parasitol Res"},{"issue":"1","key":"pgph.0006500.ref036","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41467-024-45688-z","article-title":"Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing","volume":"15","author":"M de Cesare","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"pgph.0006500.ref037","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jiaa527","article-title":"Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome","volume":"225","author":"SK Tessema","year":"2022","journal-title":"J Infect Dis"},{"key":"pgph.0006500.ref038","article-title":"Multiplexed nanopore amplicon sequencing to distinguish recrudescence from new infection in antimalarial drug trials [Internet]","author":"A Holzschuh","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"pgph.0006500.ref039","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1038\/s41598-025-94716-5","article-title":"Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health","volume":"15","author":"A Aranda-D\u00edaz","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"pgph.0006500.ref040","doi-asserted-by":"crossref","first-page":"36941","DOI":"10.1038\/s41598-025-20925-7","article-title":"Rapid multiplexed nanopore amplicon sequencing to distinguish Plasmodium falciparum recrudescence from new infection in antimalarial drug trials","volume":"15","author":"A Holzschuh","year":"2025","journal-title":"Sci Rep"},{"key":"pgph.0006500.ref041","article-title":"Assessment of different techniques and markers to distinguish recrudescence from new infection in an antimalarial therapeutic efficacy study conducted in Rwanda [Internet]","author":"SL Cantoreggi","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"pgph.0006500.ref042","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12936-025-05441-3","article-title":"Performance of molecular inversion probe DR23K and Paragon MAD4HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistance","volume":"24","author":"T Katairo","year":"2025","journal-title":"Malar J"},{"issue":"5","key":"pgph.0006500.ref043","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4621","article-title":"Molecular surveillance of malaria using the PF AmpliSeq custom assay for Plasmodium falciparum parasites from dried blood spot DNA isolates from Peru","volume":"13","author":"JH Kattenberg","year":"2023","journal-title":"Bio-Protoc"},{"issue":"9","key":"pgph.0006500.ref044","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00590-19","article-title":"Improving methods for analyzing antimalarial drug efficacy trials: molecular correction based on length-polymorphic markers msp-1, msp-2, and glurp","volume":"63","author":"S Jones","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:26:08Z","timestamp":1780075568000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006500"}},"subtitle":[],"editor":[{"given":"Xin Hui","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006500","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}